A Comparative Study of the Antihypertensive Agents on Serum Liver Enzymes ALT, AST and ALP of Hypertensive and cardiac Patients


  • Aisha Javaid University of Karachi, Karachi, Pakistan
  • Ruqaiya Hasan University of Karachi, Karachi, Pakistan
  • Aisha Zohra University of Karachi, Karachi, Pakistan
  • Zahir Hussain University of Karachi, Karachi, Pakistan




 Angiotensin-II, Catecholamines, Diuretics, Nitrates, Cardiac dysfunction, Liver injury.


Present study is done to compare serum Liver enzymes including Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST) and Alkaline Phosphatase (ALP) in hypertensive and cardiac patients. 24 patients were divided into 4 groups according to their treatment with 4 different types of antihypertensive drugs. Group I treated with Beta-blockers (1+1). Group II treated with ACE-Inhibitor once a day. Group III treated with Nitrates once a day. Group IV is taking Diuretics once a day. Data showed non-significant difference in serum ALT concentration in all groups. A significant rise (p< 0.05) in serum AST and ALP levels among hypertensive and cardiac patients is observed, ranging from 24.63-47.33U/L and 110-2484 U/L respectively when compared with normal controls. Thus, not only the risk of cardiac diseases in future might be predicted by altered levels of enzymes ALT, AST and ALP in serum but their concentrations should be monitored during the treatment of cardiac diseases to minimize the risk of cardiac arrest.


Harvey RA, Clark MA, Finkel R, Rey JA, Whalen K. Eds. Pharmacology 5th ed. Philadelphia: Lippincott Williams and Wilkins 2011; pp. 84-8, 262-11.

Katzung BG. Vasodilators and the treatment of Angina Pectoris. In: Basic and Clinical Pharmacology. 9th ed. New York: Lange Medical Books, McGraw Hill 2004; pp.186-1.

Bergmeyer HU. Methods of enzymatic analysis. 2nd ed. New York: Academic Press 1974.

Jaeger JJ, Hedegaard H. Liver function tests. In: the Danish hepatitis C website, 2002. Available from: http://home3.inet.tetle.dk/omni/alttest.html

Walker HK, Hall WD, Hurst JW, Eds. Clinical methods: The history, physical and laboratory examinations. 3rded. Boston: Butterworts 1990.

Henry JB. Plasma and serum preparation.In: Clinical diagnosis and management by laboratory methods. Philadelphia PA: WB Saunders Co 2011; p. 60.

Reitman S, Frankel S. A colorimetric method for determination of serum glutamic oxaloacetic acid and glutamic pyruvic transaminases. Am J Clin Pathol 1957; 28: 56-6.

Ahmed F, Ali SS, Shakoori AR. Sublethal effects of Danitol (Fenpropathrin) a synthetic pyrethroid, on Chinese grass carp, Ctenopharyngodon idella. Folia Biol (krakow) 1995; 43: 151-9.

Varley’s Practical Clinical Biochemistry. Varley H, Gowenlock AH, McMurray JR, Mc.Lauchlan DM, Eds. 6th ed. London: Heinemann Medical Books 1988; pp. 503, 535-2.

De Ritis F, Coltori M, Gisuti G. Serum transaminase activities in liver disease. Lancet 1972; 1: 685-2. http://dx.doi.org/10.1016/S0140-6736(72)90487-4

Chernecky CC, Berger BJ. Aspartate aminotransferase, laboratory tests and diagnostic Procedures. 3rd ed. Philadelphia: WB Saunders Co 2001; pp. 189-2.

Hasan R, Javaid A, Fatima H, Safdar W. Alterations in plasma electrolytes and serum liver enzymes induced by atenolol in common rabbits Oryctolagus cuniculus. Pak J Biol Sci 2006; 9(12): 2342-3. http://dx.doi.org/10.3923/pjbs.2006.2342.2345

Ford I, Mooijaart SP, Lloyd S, et al. The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non- cardiovascular outcomes. Int J Epidemiol 2011; 40(6): 1530-8. http://dx.doi.org/10.1093/ije/dyr172

van Deursen VM, Damman K, Hillege HL, van Beek AP, van Veldhuisen DJ, Voors AA. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Cardiac Failure 2010; 16(1): 84-6. http://dx.doi.org/10.1016/j.cardfail.2009.08.002

Lofthus DM, Stevens SR, Armstrong PW, Granger CB, Mahaffey KW. Pattern of liver enzyme elevation in acute ST – elevation myocardial infarction. Coron Artery Dis 2012; 23(1): 22-8. http://dx.doi.org/10.1097/MCA.0b013e32834e4ef1

Wannamethee SG, Whincup PH, Shaper AG, Lennon L, Sattar N. ? – glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men. Arterioscler Thromb Vasc Biol 2012; 32(3): 830-5. http://dx.doi.org/10.1161/ATVBAHA.111.240457

Pratt DS. Liver chemistry and function tests. In: Felman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease. 9th ed. Philadelphia PA: Saunders Elsevier 2010;chapt.73.




How to Cite

Aisha Javaid, Ruqaiya Hasan, Aisha Zohra, & Zahir Hussain. (2021). A Comparative Study of the Antihypertensive Agents on Serum Liver Enzymes ALT, AST and ALP of Hypertensive and cardiac Patients. Journal of Basic & Applied Sciences, 8(2), 468–472. https://doi.org/10.6000/1927-5129.2012.08.02.35



Medical Sciences